Clinical Scholar Award (CSA)

2022 HTRS/Novo Nordisk Clinical Scholar Award (CSA) in Hemophilia and Rare Bleeding Disorders

The 2022 CSA Program is underway. Deadline for applications is November 15, 2021.

HTRS and Novo Nordisk Inc. (Novo) announce the availability of one Clinical Scholar Award (CSA) focused on hemophilia and rare bleeding disorders for one academic year -- July 1, 2022 to June 30, 2023. This 2022 award is supported by an educational grant from Novo. During the clinical scholar year, the awardee is mentored by an experienced MD, MD/PhD or DO working in hemophilia or rare bleeding disorders at an established U.S.-based hemostasis treatment center (HTC).

  • For full details of the 2022 program (see expanded eligibility), click2022 REQUEST FOR PROPOSALS
  • All applications must be submitted via HTRS Online Grant Submission site: https://htrs.smapply.org
  • Deadline for 2022 applications: Monday, November 15, 2021 by 11:59 PM ET.

Quick Summary of Eligibility Requirements 2022 CSA Applicants: 

  • Applicants must be U.S.-based MDs or DOs in pediatric medicine or adult medicine
  • Applicants must have completed the first two years of fellowship in an accredited U.S. Hematology, Hematology/Oncology, or Pediatric Hematology/Oncology training program by the start of each grant cycle.
  • Applicants up to five (5) years post-fellowship as of July 1, 2022 are eligible to apply.  Individuals who have already achieved the rank of Associate Professor or who have held faculty positions for longer than five (5) years post-fellowship, are not eligible to apply.
  • Only U.S.-based MDs or DOs will be eligible to apply for a 2022 CFA grant.

Please see 2022 RFP for full eligibility requirements. 

Questions about the program may be directed to [email protected] or [email protected].

 

HTRS recognizes Novo Nordisk as a Founding Supporter of
the HTRS/Novo Nordisk CFA Program and
a supporter of one (1) 2021 HTRS/Novo Nordisk CFA 
in Hemophilia and Rare Bleeding Disorders

 

The recipient of the 2021 HTRS/Novo Nordisk Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders is:

  • Bhavya S. Doshi, MD
    Instructor, Division of Hematology | The Children's Hospital of Philadelphia
    Mentors:  Leslie J. Raffini, MD, MSCE, and Michele P. Lambert, MD, MSTR
          

 

PREVIOUS RECIPIENTS

The recipient of the 2020 HTRS/Novo Nordisk Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders is:

  • Katherine A. Regling, DO
    Children's Hospital of Michigan
    Mentors:  Meera Chitlur, MD, and Michael U. Callaghan, MD
          

The recipients of the 2019 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders are:

  • Lorraine A. Cafuir, MD
    Emory University, Atlanta, GA; Hemophilia of Georgia Center for Bleeding & Clotting Disorders
    Mentor:  Christine L. Kempton, MD      
  • Jacqueline N. Poston, MD
    University of Washington/Fred Hutchinson Cancer Research Center
    Mentor:  Rebecca Kruse-Jarres, MD, MPH

The recipients of the 2018 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders are:

  • Genevieve C. Moyer, MD, MSCS
    University of Colorado, Denver; University of Colorado Hemophilia and Thrombosis Center
    Mentor:  Tyler Buckner, MD, MSc      Co-Mentor: Marilyn Manco-Johnson, MD
  • Allyson M. Pishko, MD
    University of Pennsylvania; Penn Comprehensive Hemophilia Program
    Mentor:  Adam Cuker, MD, MS

The recipients of the 2017 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders are:

  • Michelle T. Chi, MD
    University of Tennessee, Memphis, Hemophilia & Thrombosis Treatment Center of Memphis
    Mentor:  Sandeep Rajan, MD
  • Fadi Nossair, MD
    Children’s Hospital of Orange County, Rady Children’s Hemophilia and Thrombosis Treatment Center
    Mentors:  Courtney Thornburg, MD, and Diane Nugent, MD

The recipients of the 2016 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders are:

  • Holleh Husseinzadeh, MD
  • Tiffany Lin, MD

The recipients of the 2015 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders are:

  • Duc “Bobby” Q. Tran, Jr. MD, MSc
  • Beth Bouldon Warren, MD

The recipients of the 2014 HTRS/Novo Nordisk Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders are:

  • Stacy E. Croteau, MD, MMS
  • Michael Silvey, DO

The recipient of the 2013 HTRS/Novo Nordisk Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders is:

  • Tyler W. Bucker, MD, MSc

This award program is supported by an educational grant from Novo Nordisk Inc.

top